Hazard Hub

Product quality Recalls in Canada — Page 7

340 recalls involving product quality — most are health products recalls. Newest first, updated daily from government open data.

Showing 181–210 of 340

Health Products Type II
2024-05-16

Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)

Product quality

View recall details →

Health Products Type I
2024-05-03

REDDY-SAPROPTERIN: Color change & decrease potency

Product quality

View recall details →

Health Products Type I
2024-04-17

PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)

Product quality

View recall details →

Health Products Type I
2024-04-17

PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)

Product quality

View recall details →

Health Products Type III
2024-04-17

I-131 Diagnostic Capsule: Affected lots may have decreased thyroid uptake.

Product quality

View recall details →

Health Products Type II
2024-04-10

JAMP-Guanfacine XR 4 mg: Foreign matter

Product quality - Product safety

View recall details →

Health Products Type II
2024-04-04

Honeywell Eyesaline Emergency Eyewash: deficiencies in Good Manufacturing Practices (GMP)

Product quality

View recall details →

Health Products Type II
2024-04-02

JAMP-Rabeprazole 20 mg: Affected lot may contain JAMP-Rabeprazole 10 mg

Product quality

View recall details →

Health Products Type II
2024-03-25

Viatrexx Ki-Diab: Incorrect medicinal ingredient

Product quality

View recall details →

Health Products Type III
2024-03-21

JAMP CEPHALEXIN SUSPENSION: Suspendability out of specification

Product quality

View recall details →

Health Products Type II
2024-03-12

FOLIC ACID 1MG - Affected lots exceed or may exceed the acceptable intake limit for N-nitroso-folic acid.

Product quality

View recall details →

Health Products
2024-03-04

Thyroid PX - Affected lots contain iodine levels outside of the labelled claim.

Product quality

View recall details →

Health Products Type III
2024-02-01

Klorane KeratinCaps: Affected lot contains niacinamide levels outside of the labelled claim

Product quality

View recall details →

Health Products Type II
2024-01-24

JAMP TELMISARTAN-HCT: Affected lots may contain higher dosage than the labelled dose

Product quality

View recall details →

Health Products Type II
2024-01-23

Ferrous Fumarate 300 mg: Out of Specification

Product quality

View recall details →

Health Products Type II
2024-01-15

PEDIATRIX ORAL SOLUTION 100mg: Out of specification

Product quality

View recall details →

Health Products Type II
2024-01-10

NOW® Pumpkin Seed Oil 1000 mg: Presence of Foreign Matter

Product quality

View recall details →

Health Products Type II
2023-12-29

Ashwagandha: Foreign matter

Product quality

View recall details →

Health Products Type I
2023-12-24

0.9% SODIUM CHLORIDE INJECTION, USP: Solution bags may be leaking in affected lots. (Updated with new lot numbers)

Product quality

View recall details →

Health Products Type I
2023-12-21

Bleomycin for Injection USP: Glass Particulate

Product quality

View recall details →

Health Products Type III
2023-12-12

Apo-Metoprolol 25 mg tablets: Affected lot may contain over-sized tablets

Product quality

View recall details →

Health Products Type III
2023-12-08

Taro-Dipyridamole/ASA: impurity

Product quality

View recall details →

Health Products Type II
2023-12-04

JAMP-ASA EC: out of specification

Product quality

View recall details →

Health Products Type I
2023-11-24

METRONIDAZOLE INJECTION,USP: Solution bags may be leaking in affected lots. (Updated with new lot numbers)

Product quality

View recall details →

Health Products Type II
2023-11-16

Votrient: The dissolution is out of specification in the affected lot

Product quality

View recall details →

Health Products Type II
2023-11-08

PRO-AAS EC 80: out of specification

Product quality

View recall details →

Health Products Type III
2023-11-02

FLUDEOXYGLUCOSE (18F) INJECTION: Sterility testing could not be performed for the affected lot

Product quality

View recall details →

Health Products Type III
2023-10-25

Semintra: The pH, appearance and assay is out of specification in the affected lot.

Product quality

View recall details →

Health Products Type III
2023-10-23

Perichlor Without Alcohol: Result near the stability limit for an impurity.

Product quality

View recall details →

Health Products Type II
2023-10-16

Jamp-Rehydralyte: Out of specification

Product quality

View recall details →

Other Health Products Hazards

COVID (279)Labelling (73)Contamination (61)Packaging (45)

Browse all recalls by hazard, allergen & year →